MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$86,871,857
Cash and cash
equivalents
$20,519,724
Prepaid expenses and
other current assets
$3,835,400
Accrued interest
receivable
$1,555,061
Total property, plant
and equipment,...
$31,937,324
Total current assets
$112,782,042
Long-term investments
$110,235,540
Property, plant and
equipment, net
$13,813,570
Long-term prepaid assets
$5,279,709
Financing lease
right-of-use assets
$3,474,306
Operating lease
right-of-use assets
$2,885,331
Less accumulated
depreciation and...
$18,123,754
Total assets
$248,470,498
Total liabilities and
stockholders' equity
$248,470,498
Total stockholders'
equity
$227,248,301
Total liabilities
$21,222,197
Accumulated deficit
-$129,764,052
Treasury stock, at cost
54,665 shares held at...
$5,521,246
Accumulated other
comprehensive income (loss)
-$222,764
Additional paid-in capital
$362,748,721
Total current
liabilities
$9,852,151
Warrant liabilities
$6,117,586
Finance lease
liabilities, noncurrent
$3,081,573
Operating lease
liabilities, noncurrent
$2,170,887
Common stock 0.0001 par
value 800,000,000...
$7,580
Preferred stock-Series
BPreferred Stock
$59
Preferred stock-Series
APreferred Stock
$3
Accrued expenses and
other current...
$5,386,530
Accounts payable
$3,544,958
Operating lease
liabilities, current portion
$763,705
Finance lease
liabilities, current portion
$156,958
Back
Back
Balance Sheet
SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc. (SABS)
source: myfinsight.com